Print Page   |   Contact Us   |   Sign In   |   Join Today
News & Press: Member Spotlight

This Week on the Hill, September 10 - September 14, 2018

Monday, September 10, 2018   (0 Comments)
Posted by: TCAA Staff
Share |


The House has scheduled only three days for votes this week starting Wednesday, with first votes postponed until 6:30 p.m. Included in the scheduled votes is a bill package (H.R. 3798) seeking to aid small businesses by increasing the 2010 health law's definition of a full-time employee from 30 to 40 hours per week. The topic is one of the earliest GOP health law targets and seeks to limit the incentive to reduce work hours to avoid the employer health coverage mandate.
The package also includes provisions retroactively suspending the employer mandate and further delays the implementation of an added levy on high-cost health plans (H.R. 4616), plus the repeal of a tax on tanning services (H.R. 1150) and an adjustment to IRS rules on reporting health coverage (H.R. 6718).
The chamber will also vote on several Ways and Means Committee authored measures, including a bill (H.R. 6561) seeking to spur rulemaking on a program offering integrated care to individuals 55 or older who require an institutional level of care (known as the Program for All-Inclusive Care for the Elderly [PACE]).
Other measures include an extension of the Medicare Advantage enrollment period for persons enrolled in discontinued Medicare Cost plans (H.R. 6662) and a modification of the process Medicare Administrative Contractors (MACs) use to make local coverage determinations on medical services (H.R. 3635).


The Senate returns on Wednesday and is scheduled to vote at 5:30 p.m. on a motion to end debate on the nomination of Charles P. Rettig to be commissioner of the IRS.
The Senate this week is expected to consider legislation to address the opioid crisis, a vote on which could happen as soon as Thursday afternoon. The opioids package compiles more than 70 different provisions authored in five different committees and leaves out some more controversial provisions from a similarly assembled House package. The Senate bill does not include a provision that would allow for Medicaid reimbursement for residential substance abuse facilities (a partial repeal of the IMD exclusion, H.R. 5797). It also does not include a provision that would loosen privacy restrictions on substance use disorder patients’ medical records (H.R. 6082).
The Senate also is prepared to vote on eliminating pharmacy drug price disclosure restrictions required by exchange plans and employer-offered health policies (S. 2554).


Thursday, September 13


House Small Business Committee hearing on "Now Hiring: How the Opioid Epidemic Affects Small Businesses." 11:00 a.m., 2360 Rayburn Bldg.

House Oversight and Government Reform Committee hearing on "Evaluating Federal Disaster Response and Recovery Efforts." 1:00 p.m., 2154 Rayburn Bldg.
Health Subcommittee of House Energy and Commerce Committee hearing on "Examining Barriers to Expanding Innovative, Value-Based Care in Medicare." 1:15 p.m., 2322 Rayburn Bldg.


Friday, September 14


Health Subcommittee of House Energy and Commerce Committee hearing on "Better Data and Better Outcomes: Reducing Maternal Mortality in the U.S." 9:15 a.m., 2322 Rayburn Bldg.




Wednesday, September 12


The Hill hosts a discussion on "A Healthy Start: Infant and Early Childhood Nutrition." 8:30 a.m., The Newseum, 555 Pennsylvania Avenue NW.


The Cato Institute holds a discussion on "Reclassification Risk in the Small-Group Health Insurance Market," focusing on consumer protections for small employer insurers. 12:00 p.m., 1000 Massachusetts Avenue NW, F.A. Hayek Auditorium.



Thursday, September 13


The Information Technology & Innovation Foundation's (ITIF) Center for Data Innovation holds a forum on "U.S. Data Innovation Day 2018: The Future of Data-Driven Medicine." 1:00 p.m., 421 Seventh St. NW, Washington, D.C.



Friday, September 14


The Pew Charitable Trusts holds a discussion with Commissioner Scott Gottlieb on the Food and Drug Administration's (FDA) plans to combat antibiotic resistance in human medicine and animal agriculture. 10:00 a.m., 901 E St. NW, Washington, D.C.


Association Management Software Powered by YourMembership  ::  Legal